Immunovant, Inc. IMVT Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s common stock, shares issued (in shares)?
- Immunovant, Inc. (IMVT) reported common stock, shares issued (in shares) of $203.32M in Q4 2025.
- How has Immunovant, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Immunovant, Inc.'s common stock, shares issued (in shares) increased by 38.1% year-over-year, from $147.2M to $203.32M.
- What is the long-term trend for Immunovant, Inc.'s common stock, shares issued (in shares)?
- Over 4 years (2021 to 2025), Immunovant, Inc.'s common stock, shares issued (in shares) has grown at a 14.8% compound annual growth rate (CAGR), from $97.97M to $170.11M.